BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
  • Special reports
    • Aging
    • Biosimilars
    • Artificial intelligence
    • Coronavirus
    • IVDs on the rise
    • Radiopharmaceuticals
    • Science '22 in Review
    • Top Biopharma Trends of 2022
    • Top Med-tech Trends of 2022
    • Premium reports
      • BioWorld Financings Reports
      • Disease Incidence & Prevalence Summaries

BioWorld. Link to homepage.

  • sign in
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, September 22, 2023
Home » Blogs » BioWorld MedTech Perspectives » Cancer’s cures and fantasies

BioWorld MedTech Perspectives
BioWorld MedTech Perspectives RSS FeedRSS

BioWorld MedTech

Cancer’s cures and fantasies

Aug. 7, 2014
By Mark McCarty
No Comments

The line between data and biology is...
Cancer: Where data and biology meet?

There’s no shortage of nutty thinking and absurd claims in this world, and you have to love the Interweb for giving us so much access to some of this. In that spirit, I offer two of the more out-there examples of recent vintage.

Cancer too profitable to be cured

You know the drill. There’s way too much money to be made treating cancer serially to actually come up with a cure – or to release a cure should one “accidentally” devise one.

Is it just me or is it worrisome that this sparked a conversation on LinkedIn? A couple of weeks back, someone with whom I’m linked started just such a conversation, and I flashed back to the 1980s prattle about a carburator that could give a conventionally aspirating automobile a triple-digit level of fuel economy. But Snopes says this story has been around a lot longer than that.

If GM really did have that kind of carburator, they’d have made a lot more money using it and licensing it to other car makers than the oil companies could ever have afforded as bribe money. Likewise, anyone who came up with a bona fide cure for any one of the major cancers could write their own check … plus, their name would be up there with Salk and Pasteur.

Money and immortality await, and we’re supposed to believe this conspiracy nonsense? Please. Get a life.

Just one more donation!

We’ve all seen the commercial by now, replete with images claiming “Cancer cured!” The images are vaguely reminiscent of the kinds seen in pictures of Times Square when Americans reacted to the news that World War II had come to an end. It’s such a heart-tugging thing, one that only Madison Avenue or Hollywood could pull off with so much panache.

The problem with this commercial is that it’s a very studied exercise in mixed messages. “You’ll remember this day forever,” the narrator intones, depicting ordinary people doing ordinary things, including a middle-aged man picking up a newspaper bearing the headline “Cancer Cured!” Predictably, the narrator goes out of his way to avoid saying “cure” until near the end. “We’re almost there, but we need your help … making cures happen,” he promises.

The Leukemia & Lymphoma Society is the author of this commercial, but should we not ask whether they’re playing fast and loose with the facts?

Here’s one answer from another organization dedicated to cancer research. The American Cancer Society says explicitly at its website, “sometimes [cancer] never completely goes away.” Some cancers are chronic cancers, including some leukemias. This makes the claims of the Leukemia & Lymphoma Society rather suspect, doesn’t it?

Count me among those who believe that because cancer is often a random disorder of DNA, it is equally often a disease of “information” rather than a disease of biology in the traditional sense. And given that DNA will never be quite as stable as we’d like, is it really plausible to imagine that all cancers can be cured once and for all? Or will some cancers become chronic conditions, as many experts believe?

The aforementioned commercial says “cure” only at the end, but the images suggest “eradicated.” I find the commercial troublingly disingenuous.

You must login or register in order to post a comment.

Report Abusive Comment

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Sept. 22, 2023.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for September 22, 2023.
  • Hands holding torn contract

    Quite a fix: Orthofix sacks three top execs

    BioWorld MedTech
    Orthofix Medical Inc. terminated its CEO, chief financial officer and chief legal officer in a move that plunged the stock from $18.63 at Monday’s close to $13.01...
  • New NLRP3 inflammasome inhibitors named in PTC Therapeutics patent

    BioWorld Science
    PTC Therapeutics Inc. has patented new NLRP3 inflammasome inhibitors reported to be useful...
  • Illustration of Alzheimer’s in the brain.

    Study identifies cause of death for Alzheimer’s neurons

    BioWorld
    By creating a new mouse model of Alzheimer’s disease that better recapitulated how the disease plays out in humans, investigators at KU Leuven have gained new...
BioFuture ad

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
Follow Us

Copyright ©2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing